3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Neoplasm Metastasis
1
Esophageal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Neuroendocrine
1
Anophthalmia with pulmonary hypoplasia
1
Interventions
Paclitaxel
16
pembrolizumab
15
Carboplatin
13
Specimen Handling
9
Magnetic Resonance Spectroscopy
8
Biopsy
7
Bevacizumab
7
Fulvestrant
6
olaparib
5
Taxes
5
Megestrol Acetate
5
Doxorubicin
5
Cisplatin
5
trastuzumab deruxtecan
4
dostarlimab
4
Nivolumab
4
Gemcitabine
4
palbociclib
3
durvalumab
3
Progestins
3
Oxaliplatin
3
Medroxyprogesterone Acetate
3
Leucovorin
3
Letrozole
3
Immunoglobulin G
3
Fluorouracil
3
Docetaxel
3
Disulfides
3
ribociclib
2
pertuzumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
budigalimab
×
30 days
×
Clear all
No trials found.